RIPK2 and Alzheimer disease: Therefore, our findings demonstrate the significant potential of Avn-C, which may mitigate cognitive decline in HFD-fed AD mice by suppressing neuroinflammation through the inhibition of the NOD1/RIP2/NF-κB signaling pathway.